TRBC2 and glioblastoma: TRBC2 encodes a specific region of the T-cell receptor beta-2 chain38 and has been identified as a promising biomarker for the distinction of multiple cancer types, including breast cancer, colorectal cancer, glioblastoma, hepatobiliary cancer, lung cancer and pancreatic cancer and so on39.